Long-term potentiation (LTP) is a sustained increase in synaptic efficacy that has been proposed to be a cellular substrate of learning and memory (Bliss and Collingridge 1993) . High frequency stimulation (HFS) of Schaffer collaterals effectively induces LTP in area CA1 of the hippocampus by activating calcium permeable N-methyl-D-aspartate (NMDA) receptors (Malenka and Nicoll 1999) , resulting in a rise in postsynaptic calcium that is necessary for LTP induction (Lynch et al. 1983; Malenka et al. 1988) . Activation of NMDA receptors in hippocampal slices results in the production of superoxide, which can stimulate the phosphorylation of extracellular signal-regulated kinase (ERK) (Bindokas et al. 1996; Kanterewicz et al. 1998) . Both superoxide and ERK are required for NMDA receptor-dependent LTP (English and Sweatt 1997; Klann 1998 ).
Furthermore, treatment of hippocampal slices with superoxide generated from xanthine/xanthine oxidase (X/XO) induces a long-lasting potentiation of synaptic transmission that occludes HFS-induced LTP, suggesting that activation of similar signaling pathways occurs during both types of potentiation (Knapp and Klann 2002) .
However, NMDA receptor activation is not necessary for induction of superoxideinduced potentiation, indicating that superoxide likely acts downstream of the NMDA receptor (Knapp and Klann 2002) . Because increases in postsynaptic intracellular calcium are typically required for long-term changes in synaptic efficiency, we hypothesized that there are other sources of calcium that mediate superoxide-induced potentiation.
Ryanodine receptors (RyRs) mediate calcium-induced calcium release (CICR) from intracellular stores. They are extremely sensitive to redox modifications and have been shown to modulate hippocampal LTP (reviewed in Hidalgo, 2005) . Nanomolar Page 3 of 26 concentrations of ryanodine that activate the channel enhance LTP; in contrast, inhibitory micromolar concentrations reduce LTP (Lu and Hawkins 2002) . In addition, hydrogen peroxide (H 2 O 2 ) stimulates the phosphorylation of ERK in hippocampal slices through an oxidative modification of RyRs (Kemmerling et al. 2006) . All three RyR isoforms are expressed in area CA1 of the hippocampus in adult mice, but the RyR3 subtype is significantly enriched in this region (Mori et al. 2000) . Previous studies on RyR3 knockout (KO) mice have established a role for this subtype in hippocampal synaptic plasticity and hippocampus-dependent learning tasks (Shimuta et al. 2001; Balschun et al. 1999; Kouzu et al. 2000) . RyR3 KO mice display significantly reduced LTP following various stimulation protocols (Shimuta et al. 2001; Balschun et al. 1999 ).
Redox regulation of RyR3 receptors may partially mediate these effects as single channel recordings indicate that oxidizing reagents activate the channel whereas reducing reagents inhibit it (Murayama et al. 1999 ). Thus, it is possible that RyRs, most notably RyR3, modulate the magnitude of LTP via activation of ERK.
Calcium influx through L-type voltage-gated calcium channels may also be necessary for superoxide-induced potentiation. A low concentration of H 2 O 2 (1 µM), a molecule that partially mediates superoxide-induced potentiation (Knapp and Klann 2002) , increased the magnitude of LTP (Kamsler and Segal 2003) . This effect was dependent on activation of L-type calcium channels but not NMDA receptors (Kamsler and Segal 2003) . Furthermore, a functional coupling between RyRs and L-type calcium channels has been established in the dentate gyrus and cerebellar granule cells (Welsby et al. 2006; Chavis et al. 1996) . Thus, L-type channels may be an important calcium source upstream of RyRs that are required for the redox component of LTP.
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Herein, we determined whether superoxide treatment enhanced activation of RyRs and whether RyR3 specifically was necessary for the expression of superoxideinduced potentiation in hippocampal area CA1. We found that superoxide-induced LTP was abolished in RyR3 KO mice, indicating that redox modification of this enriched subtype of RyRs is a source of calcium necessary for potentiation of synaptic transmission induced by superoxide. L-type calcium channels also were required, indicating a functional coupling of these channels with RyR3 during superoxide-induced potentiation. Moreover, increased phosphorylation of ERK following the application of superoxide to slices was mediated by RyR3 and activation of ERK was necessary for superoxide-induced LTP. These findings demonstrate that several components of signaling pathways known to modulate tetanus-induced LTP are critical for expression of superoxide-induced LTP.
Materials and Methods
Materials. Xanthine oxidase (XO), ryanodine, nifedipine, and U0124 were purchased from Calbiochem (La Jolla, CA). Xanthine (X) was purchased from Sigma (St. Louis, MO). Rabbit anti-dually phosphorylated ERK (pp-ERK) and rabbit anti-total ERK (ERK) were purchased from Promega (Madison, WI). Mouse anti-RyR was purchased from Affinity Bioreagents (Golden, CO).
Mice. Generation of the RyR3 KO mice is described elsewhere (Takeshima et al. 1996) and were kindly provided to us by Dr. Hiroshi Takeshima. The RyR3 KO mice were bred on a C57Bl6 genetic background. Pharmacology. Baseline responses were recorded for 20 min before application of any drugs. All slices were treated with 20 µg/mL X and 17 µg/mL XO for 10 min. For some experiments slices were treated with 10 µM ryanodine for 30 min before and during X/XO application. In another set of experiments slices were treated with either the MEK inhibitor U0126 (20 µM) or U0124 (an inactive analogue of U0126) 60 min before and during the X/XO application. Responses were monitored 60 min after washout of all reagents.
Tritiated ([3H]) ryanodine binding.
Hippocampal slices were prepared as described above and allowed to recover for 2 hrs in 15 mL ACSF at 30 o C. The slices (7/vial) were incubated for 10 min with 20 µg/mL X and 17 µg/mL XO (or boiled XO) and immediately snap-frozen on dry ice. The slices then were homogenized in high sucrose buffer (320 mM sucrose, 5 mM HEPES, and 10 µL/mL protease and phosphatase inhibitors) and microsomes were extracted by differential centrifugation. The pellet containing the microsome extract was resuspended in 150 mM NaCl, 50 mM Tris pH 7.5, 0.1% CHAPS, and 10 µL/mL protease and phosphatase inhibitors, and total protein concentrations were determined . Hippocampal slices from 10 mice were used for 7
replicates of the drug treatment. Microsome extracts from all 7 replicates were pooled to provide 300 µg of protein for 2 binding assays, requiring 150 µg of protein per assay.
The 150 µg of protein was divided into 5 tubes containing 30 µg per tube of which 3 were used to measure specific activity and the other 2 for nonspecific activity.
Microsome extracts were incubated in 300 mM NaCl, 100 µM CaCl 2 , 0.1 mg/mL BSA, 0.1% CHAPS, 50 mM MOPS pH 7.4, and 10 nM [3H] ryanodine to measure specific activity. To measure nonspecific activity, 10 µM cold ryanodine was added to the buffer.
Samples were incubated 14-16 hours and the unbound tritium was washed through a filter with buffer. The activity left on the filter was measured by a scintillation counter.
Western blot analysis. Hippocampal slices were prepared as described above and allowed to recover for 2 hrs in 15 mL ACSF at 30 o C. The slices (3/vial) were incubated for 10 min with 20 µg/mL X and 17 µg/mL XO (or boiled XO) and snap frozen on dry ice 5 min after treatment. The slices then were homogenized in high sucrose buffer (320 mM sucrose, 5 mM HEPES, and 10 µL/mL protease and phosphatase inhibitors), and total protein concentrations were determined. Ten micrograms of protein were loaded on a 12% SDS-PAGE gel and resolved by electrophoresis. Separated proteins were transferred from the SDS-PAGE gel to Immobilon-P membranes (Millipore, Bedford, MA) using a transfer tank. Following transfer the membranes were incubated in blocking solution containing 0.2% I-block, 50 mM Tris-HCl pH 7.5, 150 mM NaCl, and 0.1% Tween-20 at room temperature (RT) for 1 hr. The blots then were incubated for 1 hr at RT with primary antibodies (Ab) against pp-ERK diluted 1:3000 in blocking solution. The blots were washed 3 times for 15 min in Tris-buffered saline (50 mM Tris-HCl pH 7.5, 150 mM NaCl, and 0.05% Tween-20), then incubated at RT for 1 hr with secondary (horseradish peroxidase-conjugated anti-rabbit) diluted 1:10,000 in blocking solution.
The blots were washed again and exposed to Kodak film using ECL chemiluminescence. Normalization of pp-ERK to total ERK for all experiments was achieved by stripping and probing the blots for total ERK following the protocol described above. For RyR blots, 20 µg of protein from microsome extracts were loaded into a 5% SDS-PAGE gel. Blots were incubated with anti-RyR Ab for 2.5 hrs at RT diluted 1:2000 in blocking solution. The remainder of the protocol was performed as described above.
Data analysis.
The results for all experiments are presented as means ± the standard error of the means. For comparisons between two groups a two-tailed Student's t test was used. Comparisons between multiple groups were analyzed using a one-way analysis of variance (ANOVA) followed by a Newman-Keuls multiple comparisons test.
Error probabilities with p values <0.05 were considered statistically significant.
Results

Superoxide modulates activation of RyRs
The unique redox sensitivity of RyRs prompted us to investigate whether a brief exposure to superoxide treatment would enhance their activation in the hippocampus.
The degree of activation of RyRs isolated from hippocampal slices immediately (Fig. 1A inset) . A similar 'doublet' representing RyR3 and RyR1/RyR2 was observed previously (Jeyakumar et al.,1998) 
Activation of RyR3 is necessary for superoxide-induced potentiation
In light of the ability of superoxide to modulate RyR activity, we hypothesized that RyR-mediated calcium-induced calcium release (CICR) from intracellular stores is a calcium source mediating superoxide-induced potentiation. Treatment of hippocampal slices for ten minutes with X/XO induced a transient depression followed by a significant long-lasting potentiation of synaptic transmission (fEPSP slope = 116 ± 0.4% of baseline, n=7; Fig. 1B) . The superoxide-induced potentiation was blocked and the recovery from depression prolonged when the hippocampal slices were treated with a concentration of ryanodine that inhibits function of all RyRs (10 µM) for half an hour before and during addition of X/XO (fEPSP slope = 95 ± 0.6% of baseline, n=8; Fig. 1B and 1E). These results are consistent with the hypothesis that CICR through RyRs mediates superoxide-induced potentiation.
We also examined superoxide-induced potentiation in RyR3 KO mice. Although the recovery from depression was the same in RyR3 KO and WT mice, there was a significant suppression of potentiation in the RyR3 KO mice during the last twenty minutes of the experiment (fEPSP slope = 99 ± 0.8% of baseline, n=6; Fig. 1C and 1E ).
When the other RyR subtypes were pharmacologically blocked in hippocampal slices from the RyR3 KO mice, the results were indistinguishable from those obtained from wild-type slices exposed to the same pharmacological conditions except for a significant (p<0.001, paired t-test) change in baseline synaptic transmission following the addition of 10 µM ryanodine (fEPSP slope = 106 ± 0.24% of baseline for WT and 95 ± 0.51% of baseline for RyR3 KO). These changes in baseline synaptic transmission may be a result of this concentration of ryanodine (10 µM) causing a long-lasting subconductance state rather than fully inhibiting activity of the receptor (Murayama et al. 1999) . Taken together, these data indicate that expression of superoxide-induced potentiation is mediated by RyR3 activation.
RyR3 is required for superoxide-induced activation of ERK
Phosphorylation of ERK is stimulated in hippocampal slices following superoxide treatment (Kanterewicz et al. 1998) . We hypothesized that RyR activation, specifically RyR3, is responsible for this effect. Consistent with previous findings, we found that superoxide significantly enhanced the phosphorylation of ERK2 (129 ± 10.7% of control, n=7; Fig. 2A ). Phosphorylation of ERK2 was not altered by superoxide in hippocampal slices pretreated with 10 µM ryanodine (94 ± 11.4 % of control, n=6; Fig. 2A ) or in those from RyR3 KO mice (91 ± 3.2% of control, n=4; Fig. 2B ). Thus, our findings indicate that superoxide-induced activation of ERK is RyR3-dependent.
ERK is Required for Superoxide-induced Potentiation
Considering the aforementioned superoxide-induced activation of ERK, we postulated that this event is a component of the signaling cascades that mediate superoxide-induced potentiation. Blockade of ERK activation achieved by one hour incubation with the MEK inhibitor U0126 before and during X/XO treatment enhanced the transient depression and eliminated the potentiation (fEPSP slope = 100 ± 0.6% of baseline, n=10; Fig. 2C-D) . Superoxide-induced potentiation was observed in hippocampal slices treated in the same manner with U0124, the inactive analogue of the MEK inhibitor (fEPSP slope = 111 ± 1.0% of baseline, n=8; Fig. 2C-D) . These results strongly suggest that superoxide is a messenger molecule that induces potentiation through similar pathways activated during HFS-induced LTP.
Superoxide-induced Potentiation is Dependent on L-type Calcium Channel Activation
Calcium flux through ryanodine receptors is induced in the presence of calcium, making it a calcium amplification system. This suggests the presence of an additional calcium source upstream of RyR3 that is necessary for superoxide-induced potentiation.
We investigated the contribution of L-type calcium channels because they have been shown to be a component of signaling cascades involving RyRs in both the dentate gyrus and cerebellum (Welsby et al. 2006; Chavis et al. 1996) . Application of the L-type calcium channel blocker nifedipine (10 µM) for half an hour before and during addition of X/XO blocked superoxide-induced potentiation (fEPSP slope = 97 ± 1.0% of baseline, n=6; Fig. 3 ). These results indicate that a functional coupling between RyR3 and L-type calcium channels are involved in superoxide-induced potentiation.
Discussion
We have demonstrated that RyR3 is necessary for superoxide-induced potentiation of hippocampal synaptic transmission and superoxide-induced activation of ERK. This was accomplished by showing that treatment of hippocampal slices with X/XO activates RyRs and that this activation is necessary for superoxide-induced potentiation. Analysis of superoxide-induced potentiation in RyR3 KO mice and in the presence of the L-type calcium channel blocker nifedipine revealed that calcium from both of these sources is required for the potentiating effects of superoxide on synaptic transmission. In addition, we found that activation of RyR3 is necessary for superoxide to enhance ERK phosphorylation and that ERK is a component of the signaling cascade underlying superoxide-induced potentiation. These data suggest that superoxide is a messenger molecule capable of modulating LTP through redox modifications of RyRs.
Superoxide previously has been established as a signaling molecule required for LTP induction, but its targets have remained elusive (Klann 1998; Thiels et al. 2000; Kishida and Klann, 2007) . Superoxide-induced potentiation and HFS-induced LTP occlude one another, suggesting that they share similar signaling pathways. Thus, superoxide-induced potentiation is a viable paradigm that could be used to elucidate the targets of superoxide during LTP induction (Knapp and Klann 2002) . The effectiveness of this paradigm for determining targets of superoxide during LTP induction is illustrated in studies focusing on protein kinase C (PKC). Persistent activation of PKC is necessary for LTP induction and maintenance (Wang and Feng, 1992; Klann et al. 1993) . The increase in cofactor-dependent PKC activity in area CA1 of hippocampal slices observed following HFS was abrogated by the superoxide specific scavenger superoxide dismutase (SOD) . Potentiation induced by superoxide is also dependent on persistent PKC activation (Knapp and Klann 2002) . The results of our present study have identified two more components, RyR3 and ERK, of the signaling cascade necessary for superoxide-induced potentiation that are also important for LTP.
There are many potential neuronal sources of superoxide including mitochondria, monoamine oxidase, cyclooxygenase, nitric oxide synthase, and NADPH oxidase (Kishida and Klann 2007) . The only one of the aforementioned sources directly linked to synaptic plasticity and learning and memory is NADPH oxidase. Pharmacological inhibitors of NADPH oxidase blocked LTP and NMDA receptor-dependent activation of ERK in area CA1 of the hippocampus (Kishida et al. 2006; Kishida et al. 2005) . LTP also was abolished in mice lacking either one of two subunits, gp91 phox or p47 phox , critical for NADPH oxidase-dependent superoxide production (Kishida et al. 2006 ). These mice display mild deficits in hippocampus-dependent memory tasks as well (Kishida et al. 2006) . Thus, NADPH oxidase is likely one of the sources of superoxide required for LTP and memory function.
Although X/XO is a superoxide-generating system, it is not our intention to suggest that superoxide is the only reactive oxygen species (ROS) involved in inducing superoxide-induced potentiation. Superoxide dismutase (SOD) is a scavenger of superoxide that catalyzes the conversion of superoxide to hydrogen peroxide (H 2 O 2 ), which can react with iron ions to form hydroxyl radicals (OH-) (Kamsler and Segal 2004) . Catalase, an enzyme that converts H 2 O 2 to water and oxygen molecules, was shown to attenuate superoxide-induced potentiation and completely block the transient depression in synaptic transmission observed during X/XO treatment in hippocampal slices from rats (Knapp and Klann 2002) . A low concentration of H 2 O 2 (1 µM) was shown to stimulate ERK and cAMP responsive element-binding protein (CREB) phosphorylation, both of which are critical for LTP and memory function (reviewed in Silva 2003) , in hippocampal slices that was dependent on activation of RyRs (Kemmerling et al. 2006) . Inhibition of ERK phosphorylation triggered by H 2 O 2 by the MEK inhibitor U0126 may be responsible for the enhancement of the transient depression observed (Fig. 2C) . Furthermore, in cultured hippocampal neurons H 2 O 2 -induced phosphorylation of ERK and CREB was accompanied by increased Sglutathionylation, a type of oxidative modification, of RyRs (Kemmerling et al. 2006 ).
Thus, oxidative modifications of RyRs are likely responsible for the increase in RyR activation observed following superoxide treatment (Hidalgo 2005) .
Our results also suggest the possibility of a role for OH• in superoxide-induced potentiation. Potentiation was attenuated slightly in hippocampal slices treated with X/XO and the inactive analogue of the MEK inhibitor, U0124, compared to those only treated with X/XO. We suspect that this may have occurred because the U0124 is dissolved in dimethylsulfoxide (DMSO), which acts as a scavenger of OH•. In support of this idea is the finding that treatment of PC12 cells with iron, which accelerates the conversion of H 2 O 2 to OH•, enhances phosphorylation of ERK and induces calcium transients that were blocked by ryanodine (Munoz et al. 2006) . Our results are in agreement with current literature suggesting that multiple ROS can regulate RyRs and are important modulators of synaptic plasticity.
There is evidence for the involvement of both pre-and postsynaptic changes in superoxide-induced potentiation. Analysis of paired pulse facilitation (PPF) showed an increase in PPF immediately after washout of X/XO, which corresponds to the transient depression observed (Knapp and Klann 2002) . A decrease in PPF also was observed 20 and 30 minutes after washout of X/XO, but not at any later time points (Knapp and Klann 2002) . These findings suggest the possibility of a presynaptic locus for these phases of plasticity. The effects of ryanodine on baseline synaptic transmission also may be mediated presynaptically. Ryanodine (2 µM) increases the probability of successful transmission when there is a low probability (P ranging from 0.03 -0.32) of release at CA3-CA1 synapses and these changes are accompanied by a decreased PPR (the ratio of the mean amplitude of all events including failures after the second stimulation over the mean amplitude of all events including failures after the first stimulation) and coefficient of variation (Magueresse and Cherubini 2007) . RyRs are present both pre-and postsynaptically and superoxide in the extracellular space has been demonstrated to be important for LTP induction ), so it is reasonable to consider that both pre-and postsynaptic components of the synapse are important for superoxide-induced potentiation.
In conclusion, our studies are the first to show that redox modulation of RyRs is able to induce plasticity in area CA1 of the hippocampus. Our data also reveal two more components of the redox signaling module, RyR3 and ERK, that mediate both superoxide-induced potentiation and HFS-induced LTP (Shimuta et al. 2001; English and Sweatt, 1997) . These results are consistent with the idea that superoxide produced in area CA1 following HFS is important for the induction of LTP via the oxidative modification of RyRs. This question remains to be addressed in future studies. Stable baseline responses were recorded for 20 min before hippocampal slices were incubated with 20 µg/mL X and 17 µg/mL XO for 10 min or with 10 µM nifedipine for 30 min before and during X/XO application (indicated by bars). Responses were recorded for 60 minutes after drug washout. X/XO treatment (filled squares, n=7) induced a transient depression followed by a modest, but significant (p<0.0001, paired t-test) longlasting potentiation (fEPSP slope = 116 ± 0.4% of baseline) that was blocked by preincubation with nifedipine (open squares, n=6; fEPSP slope = 97 ± 1.0% of baseline). Representative traces taken from the points marked A and B are displayed.
Scale bars represent one mV on the Y axis and 10 msec on the X axis.
